Dendrobium officinalis inhibited tumor growth in non-small cell lung cancer | Zendy

Chen Pang | Zendy; Xiuling Zhang | Zendy; Min Huang | Zendy; Guangyuan Xie | Zendy; Shanshan Liu | Zendy; Xingjiang Ye | Zendy; Xiliu Zhang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dendrobium officinalis inhibited tumor growth in non-small cell lung cancer

Author(s) -

Chen Pang,

Xiuling Zhang,

Min Huang,

Guangyuan Xie,

Shanshan Liu,

Xingjiang Ye,

Xiliu Zhang

Publication year - 2020

Publication title -

translational cancer research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.254

H-Index - 30

eISSN - 2219-6803

pISSN - 2218-676X

DOI - 10.21037/tcr.2020.02.79

Subject(s) - dendrobium , lung cancer , medicine , cancer , pharmacology , a549 cell , nude mouse , cancer research , traditional medicine

Lung cancer is always a severe disease (1) and is one of the most common malignant tumors in the world (2). In Chinese urban population, lung cancer has become the first cause of death of malignant tumors. It can be divided into 2 types, small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) (2). NSCLC accounts for about 80% of all lung cancers, and about 75% of patients have been found in the middle and advanced stage (3), with a meager 5-year survival rate. NSCLC can also be divided into Original Article

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research